Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02130869
Title A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

germ cell cancer

neuroblastoma

renal Wilms' tumor

brain cancer

Hodgkin's lymphoma

non-Hodgkin lymphoma

sarcoma

retinoblastoma

Therapies

Bendamustine + Cytarabine + Etoposide

Busulfan + Hu14.18K322A

Aldesleukin + Melphalan + Sargramostim

Filgrastim

Carboplatin + Etoposide

Age Groups: child
Covered Countries USA


No variant requirements are available.